‘New Phase 3 Data Presented At WORLDSymposium Reinforce Nexviazyme As Potential New Standard Of Care For All People Living With Late-Onset Pompe Disease’
New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with
